Articles

Poll

Podcasts

Slideshows

Videos

The previously approved technology has already accomplished over 10,000 procedures for patients with various heart diseases, primarily including atrial fibrillation.

FDA Approves Updated VARIPULSE Platform Irrigation Flow Rate for Heart Disease

BaxHTN trial results showed baxdrostat led to a significant reduction of systolic blood pressure compared to placebo, with a favorable safety profile.

Baxdrostat Meets Efficacy Endpoint in Phase 3 Trial for Resistant Hypertension

Treatment with baxdrostat resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia in the phase 2a SPARK trial.

Phase 2a Baxdrostat Data Show Promise for Primary Aldosteronism

Finerenone gains FDA approval for heart failure treatment, offering new hope for patients with reduced ejection fraction and improving care options.

FDA Approves Finerenone (Kerendia) for Heart Failure with Ejection Fraction of 40% or More

The FDA also announced an updated PDUFA date of December 13, 2025 for the self-administered nasal spray.

FDA Accepts Response to CRL for Etripamil (Cardamyst) for Treating PSVT

Capricor Therapeutics intends to resubmit a BLA for the potential first-in-class treatment with topline data from the ongoing HOPE-3 trial in Q3 2025.

FDA Issues CRL to Deramiocel for Treating Cardiomyopathy Secondary to DMD

These data resulted from a sub-study of the open-label extension (OLE) of the randomized, placebo-controlled phase 3 ‘Balance’ analysis.

Study Highlights Experiences with Familial Chylomicronemia Syndrome After Olezarsen Use

New research highlights significant declines in cardiovascular screenings for U.S. adults with disabilities during the COVID-19 pandemic, revealing ongoing healthcare disparities.

COVID-19 Exacerbated Healthcare Utilization Disparities for People With Disabilities

Contrary to earlier research, a Framingham Heart Study analysis found no significant dementia risk tied to transient ischemic attack over 2 decades.

No Long-Term Dementia Risk Linked to Transient Ischemic Attack, 20-Year Study Finds

Actual LLT use was significantly lower than the proportion of guideline-eligible patients for statins, ezetimibe, and PCSK9i.

Optimizing Lipid Lowering Drug Use Could Yield Major Clinical, Public Health Benefits

Dyslipidemia

Arrhythmia

Cardiomyopathy

Structural Heart Disease

Atherosclerotic Cardiovascular Disease

Heart Failure

The HCPLive heart failure page is a resource for medical news and expert insights on HF. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for heart disease, reduced and preserved ejection fraction, and more.

Hypertension

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.

Stroke

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.

Venous Thromboembolism

The HCPLive venous thromboembolism page is a resource for medical news and expert insights on VTE. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...